Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI117677

Diminished expression of CD40 ligand by activated neonatal T cells.

S Nonoyama, L A Penix, C P Edwards, D B Lewis, S Ito, A Aruffo, C B Wilson, and H D Ochs

Department of Pediatrics, University of Washington, Seattle 98195.

Find articles by Nonoyama, S. in: PubMed | Google Scholar

Department of Pediatrics, University of Washington, Seattle 98195.

Find articles by Penix, L. in: PubMed | Google Scholar

Department of Pediatrics, University of Washington, Seattle 98195.

Find articles by Edwards, C. in: PubMed | Google Scholar

Department of Pediatrics, University of Washington, Seattle 98195.

Find articles by Lewis, D. in: PubMed | Google Scholar

Department of Pediatrics, University of Washington, Seattle 98195.

Find articles by Ito, S. in: PubMed | Google Scholar

Department of Pediatrics, University of Washington, Seattle 98195.

Find articles by Aruffo, A. in: PubMed | Google Scholar

Department of Pediatrics, University of Washington, Seattle 98195.

Find articles by Wilson, C. in: PubMed | Google Scholar

Department of Pediatrics, University of Washington, Seattle 98195.

Find articles by Ochs, H. in: PubMed | Google Scholar

Published January 1, 1995 - More info

Published in Volume 95, Issue 1 on January 1, 1995
J Clin Invest. 1995;95(1):66–75. https://doi.org/10.1172/JCI117677.
© 1995 The American Society for Clinical Investigation
Published January 1, 1995 - Version history
View PDF
Abstract

CD40 and CD40 ligand (gp39) mediate contact-dependent T-B cell interaction. We determined the expression of CD40 ligand by activated neonatal T cells and the response of neonatal B cells when activated through CD40. Although expression of CD40 ligand peaked simultaneously in both activated adult and neonatal cells, neonatal T cells expressed significantly less CD40 ligand surface protein and mRNA than adult T cells. Activated thymocytes also expressed far less CD40 ligand than adult T cells. Consistent with these results, activated neonatal T cells exhibited less helper function than activated adult T cells. Neonatal T cells primed and restimulated in vitro expressed CD40 ligand in amounts comparable with adult T cells and provided B cell help more effectively. This suggests that the poor expression of CD40 ligand reflects antigenic naiveté rather than an intrinsic defect of neonatal T cells. Neonatal B cells cultured with soluble CD40 ligand (sgp39) and IL-10 produced IgM in amounts comparable with adult cells, but much less IgG and IgA. Nevertheless, neonatal B cells were capable of proliferation and class switching, since sgp39 and IL-4 induced proliferation and IgE production comparable to adult B cells and production of modest amounts of IgG. Together, these results indicate that diminished CD40 ligand expression, along with decreased production of lymphokines, may be responsible, at least in part, for the transient immunodeficiency observed in human neonates.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 66
page 66
icon of scanned page 67
page 67
icon of scanned page 68
page 68
icon of scanned page 69
page 69
icon of scanned page 70
page 70
icon of scanned page 71
page 71
icon of scanned page 72
page 72
icon of scanned page 73
page 73
icon of scanned page 74
page 74
icon of scanned page 75
page 75
Version history
  • Version 1 (January 1, 1995): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts